Detalhe da pesquisa
1.
Minimal residual disease negativity and lenalidomide maintenance therapy are associated with superior survival outcomes in multiple myeloma.
Bone Marrow Transplant
; 55(6): 1137-1146, 2020 06.
Artigo
Inglês
| MEDLINE | ID: mdl-31992845